Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance Spectroscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Physical exercise may increase plasma concentration of high-density lipoprotein-cholesterol in patients with alzheimer's disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Microstate Changes Associated With Alzheimer's Disease in Persons With Down Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Blocking of efflux transporters in rats improves translational validation of brain radioligands

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future

    Research output: Contribution to journalReviewpeer-review

  3. Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Chemogenetic studies with the ligand clozapine N-oxide (CNO) are predicated upon the assumption that CNO is devoid of actions at natural neuroreceptors. However, recent evidence shows that CNO may be converted back to clozapine (CLZ) in vivo, which could yield plasma concentrations that may be sufficient to occupy inter alia dopamine D2/3 and serotonin 5HT2A receptors in living brain. To test this phenomenon, we measured striatal dopamine D2/3 receptor occupancy with [18F]fallypride PET and serotonin 5HT2A occupancy ex vivo using [18F]MH.MZ. We found a CNO dose-dependent effect on the availability of both neuroreceptor sites. In parallel MR spectroscopy experiments, we found that CNO reduced creatine + phosphcreatine (Cr+PCr) and increased N-acetylaspartate + N-acetylaspartylglutamate (NAA+NAAG) signals in the prefrontal cortex, and also reduced the glutamate signal in dorsal striatum, with peak effect at 2 mg/kg. Thus, our findings suggest that conversion of CNO to CLZ in living rats imparts significant occupancy at endogenous neuroreceptors and significant changes to neurometabolite levels.

Original languageEnglish
JournalFrontiers in Neuroscience
Volume13
Pages (from-to)187
ISSN1662-4548
DOIs
Publication statusPublished - 2019

ID: 59056092